Radiopharmaceuticals Market Research Reports & Industry Analysis
A radiopharmaceutical, which involves the use of radioactive agents in vivo to diagnose or treat specific diseases and conditions, generally consists of two components which determine its characteristics and clinical potential. The most common diagnostic molecular imaging agents use radioactive isotopes as the signal source. A radioactive isotope -- a radioisotope or radionuclide -- is a natural or artificially created isotope with an unstable nucleus that decays -- emitting alpha or beta particles, positrons, or gamma rays. As it decays, it loses mass and energy, until a stable isotope develops. For most elements, both stable and radioactive isotopes are known.
Examples of radioisotopes commonly combined with pharmaceutically-active molecules to form radiopharmaceuticals include technetium-99m, gallium-67, Iodine-123, Iodine-13, Thallium-201, Fluorine-18, and Indium-111.
A number of SPECT radiopharmaceuticals incorporate antibody and peptide formulations that can be targeted to specific tissue receptors, allowing one to discriminate healthy from diseased tissue with a high confidence level. However, the more specific the targeting agent is, the more difficult it is to interpret its position anatomically, since there are fewer landmarks.
Radiopharmaceuticals Industry Research & Market Reports
-
The 2025-2030 World Outlook for Nuclear Medicine-Radiopharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for SPECT Radioisotope Radiopharmaceuticals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Diagnostic Radiopharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Diagnostic Radiopharmaceutical Imaging Agents
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals and Contrast Media
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Medical Cyclotrons
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals-Nuclear Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceutical and Therapeutics
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Diagnostic Radiopharmaceuticals and Contrast Media
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Imaging Agents
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Global Radiopharmaceutical Injector Market Growth 2024-2030
... Injector is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Radiopharmaceutical Injector market. Radiopharmaceutical Injector ... Read More
-
Radiopharmaceuticals Global Market Report 2024
... Covering: Cardinal Health; Curium Pharma; Siemens Healthineers AG; Novartis AG; General Electric Company (GE) Radiopharmaceuticals Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they ... Read More
-
Global Diagnostic Radiopharmaceuticals and Contrast Media - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029
... 2024, and is expected to reach USD 13.01 billion by 2029, growing at a CAGR of 6.81% during the forecast period (2024-2029). The COVID-19 pandemic is expected to have impacted the growth of the studied ... Read More
-
Radiopharmaceutical Theranostics Global Market Report 2024
... 177; Copper (Cu) 67; Copper (Cu) 644) By Indication: Oncology; Cardiology; Neurology5) By End User: Hospitals; Diagnostic Imaging Centers; Academic And Research InstitutesCovering: Cardinal Health Inc.; AstraZeneca Plc; GE HealthCare Technologies Inc.; Bayer AG; China ... Read More
-
Global Radiopharmaceuticals in Nuclear Medical Market Growth 2024-2030
... downstream market, the Radiopharmaceuticals in Nuclear Medical is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Radiopharmaceuticals in Nuclear Medicine Market Growth 2024-2030
... in downstream market, the Radiopharmaceuticals in Nuclear Medicine is forecast to a readjusted size of US$ 6696.3 million by 2030 with a CAGR of 5.2% during review period. The research report highlights the growth potential ... Read More
-
North America Radiopharmaceutical Theranostics Market Forecast to 2028 - Regional Analysis - by Product Type [Alpha Emitters, Beta Emitters, and Positron Emission Tomography (PET) Tracers], Radioisotope [Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fluorine-18 (18F), Yttrium 90 (Y-90), Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic Imaging Centers, Academic and Research Institutes, and Others)
... Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, and Others], Source (Nuclear Reactors and Cyclotrons), Application [Targeted Therapeutic (Rx) and Companion Diagnostic (CDx)], Indication (Oncology, Cardiology, Neurology, and Others), and End User (Hospitals, Diagnostic ... Read More
-
Middle East and Africa Radiopharmaceuticals Market, By Type (Diagnostic, Therapeutic); By Application (Cancer, Cardiology); By Source (Nuclear Reactors, Cyclotrons); By End Use (Hospitals & Clinics, Medical Imaging Centers); By Country (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East and Africa), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... increasing demand for nuclear medicine procedures, rising investments in healthcare infrastructure, and expanding applications. BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Middle East and Africa Radiopharmaceuticals ... Read More
-
Theranostics Market by Product (Diagnostic imaging (PET, CT, MRI), Radiopharmaceuticals (Lu-177, Sm-153, Ra-223, I-131), Biomarker screening, Software), Application (Prostate Cancer, Bone metastasis), & Stakeholder Expectations - Global Forecast to 2028
... projected to reach USD 4.3 billion by 2028 from USD 2.1 billion in 2023, at a CAGR of 15.5% from 2023 to 2028. Factors such as rising baby boomer population and advances in research and ... Read More
-
Automated Radiosynthesis Module Market Report by Type (Fully Automated, Semi-Automated), Application (Hospitals, Diagnostic Labs, Radiology Clinics, and Others), and Region 2024-2032
... forward, IMARC Group expects the market to reach US$ 57.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.72% during 2024-2032. The increasing prevalence of various chronic and cardiovascular diseases, especially amongst the geriatric ... Read More
-
Global Radiopharmaceutical (Oral Route) Market Research Report 2024(Status and Outlook)
... by 2029, exhibiting a CAGR of 3.90% during the forecast period. This report provides a deep insight into the global Radiopharmaceutical (Oral Route) market covering all its essential aspects. This ranges from a macro overview ... Read More
-
Global Diagnostic Radiopharmaceuticals Market Research Report 2024(Status and Outlook)
... medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases. The ... Read More
-
Global Radiopharmaceutical Therapy Market Research Report 2024(Status and Outlook)
... exhibiting a CAGR of 3.90% during the forecast period. This report provides a deep insight into the global Radiopharmaceutical Therapy market covering all its essential aspects. This ranges from a macro overview of the market ... Read More
-
Global Radiopharmaceutical Production Systems Market Research Report 2024(Status and Outlook)
... estimated at USD 7012.98 million in 2023 and is projected to reach USD 8822.59 million by 2029, exhibiting a CAGR of 3.90% during the forecast period. This report provides a deep insight into the global ... Read More
Research Assistance
